RP-HPLC Method Development and Validation of Tapentadol Hydrochloride in Bulk and Pharmaceutical Formulations
G. Sangeetha, M. Swamivel Manickam & P. Sanil Kumar · Journal of Pharmaceutical Research International · 2021
Objective: Tapentadol Hydrochloride was approved (November 2008) by the United States Food and Drug Administration for the relief of moderate to severe pain. It is an opioid analgesic, acts by dual mechanism as opioid receptor agonist and norepinephrine reuptake inhibitor. The pr...
Open access
Research Article
10.9734/jpri/2021/v33i1131239